Contents

Current Drug Therapy, Volume 4 - Number 1

Editorial

, 4(1): 1

Joachim F. Wernicke


DOI: 10.2174/157488509787081831




Anti Oxidant Property of New Cephalosporin-Aminoglycoside Fixed Dose Combination

, 4(1): 2 - 6

Manu Chaudhary, Arvind Soni, Vivek Kumar Dwivedi and Rajesh Sehgal


DOI: 10.2174/157488509787081877




Paliperidone: A Clinical Review

, 4(1): 7 - 11

Ben Green


DOI: 10.2174/157488509787081903




Sinus Node If Channel Inhibition – A New Therapeutic Approach to Heart Rate Lowering

, 4(1): 12 - 18

Anne E. Scott, Kirsten Kruszewski and Stephen J. Leslie


DOI: 10.2174/157488509787081859




Unlocking the Molecular Mechanisms of DNA Repair and Platinum Drug Resistance in Cancer Chemotherapy

, 4(1): 19 - 28

Jing Jie Yu


DOI: 10.2174/157488509787081895




A Role of DEAD-Box RNA Helicase rck/p54 in Cancer Cells

, 4(1): 29 - 37

Yukihiro Akao


DOI: 10.2174/157488509787081912




Natural and Synthetic Furanocoumarins as Treatment for Vitiligo and Psoriasis

, 4(1): 38 - 58

Filomena Conforti, Mariangela Marrelli, Federica Menichini, Marco Bonesi, Giancarlo Statti, Eugenio Provenzano and Francesco Menichini


DOI: 10.2174/157488509787081886




Trimetazidine: Does it Actually Reduce QT Dispersion After First Acute Myocardial Infarction?

, 4(1): 59 - 64

Khaled El-Meniawy, Hanan Hafez, Hala Bamatraf and Wail Nammas


DOI: 10.2174/157488509787081822




Pharmacological Overview and Future Perspectives of Cholinergic Therapy in Alzheimers Disease

, 4(1): 65 - 72

Hiroo Ogura


DOI: 10.2174/157488509787081868




In Vitro Microbial Efficacy of Sulbactomax: A Novel Fixed Dose Combination of Ceftriaxone Sulbactam and Ceftriaxone Alone

, 4(1): 73 - 77

Sanjay Mohan Shrivastava, Sandeep Saurabh, Dharmendra Rai, Vivek Kumar Dwivedi and Manu Chaudhary


DOI: 10.2174/157488509787081840




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science